These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 684758

  • 21. The B-vitamin group and the activity of hepatic microsomal mixed-function oxidases of the growing Wistar rat.
    Miltenberger R, Oltersdorf U.
    Br J Nutr; 1978 Jan; 39(1):127-37. PubMed ID: 619964
    [Abstract] [Full Text] [Related]

  • 22. Kinetic characterization of CYP2E1 inhibition in vivo and in vitro by the chloroethylenes.
    Lilly PD, Thornton-Manning JR, Gargas ML, Clewell HJ, Andersen ME.
    Arch Toxicol; 1998 Oct; 72(10):609-21. PubMed ID: 9851676
    [Abstract] [Full Text] [Related]

  • 23. Dantrolene inhibition of the hepatic mixed function oxidase system.
    Francis KT, Hamrick ME.
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):69-80. PubMed ID: 441518
    [Abstract] [Full Text] [Related]

  • 24. Interactions between ethanol metabolism and mixed-function oxidation in perfused rat liver: inhibition of p-nitroanisole O-demethylation.
    Reinke LA, Kauffman FC, Belinsky SA, Thurman RG.
    J Pharmacol Exp Ther; 1980 Apr; 213(1):70-8. PubMed ID: 6987376
    [No Abstract] [Full Text] [Related]

  • 25. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
    Atal CK, Dubey RK, Singh J.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):258-62. PubMed ID: 3917507
    [Abstract] [Full Text] [Related]

  • 26. In vitro biotransformation of 1,1-dichloroethylene by hepatic cytochrome P-450 2E1 in mice.
    Lee RP, Forkert PG.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):371-6. PubMed ID: 8035334
    [Abstract] [Full Text] [Related]

  • 27. Rapid, substrate-specific, and dose-dependent deactivation of liver cytosolic glutathione S-transferases in vivo by 1,1-dichloroethylene.
    Moslen MT, Reynolds ES.
    Res Commun Chem Pathol Pharmacol; 1985 Jan; 47(1):59-72. PubMed ID: 3983471
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of hepatic microsomal drug metabolism in rats by five calcium antagonists.
    Mäenpää J, Ruskoaho H, Pelkonen O.
    Pharmacol Toxicol; 1989 May; 64(5):446-50. PubMed ID: 2771871
    [Abstract] [Full Text] [Related]

  • 29. Temporal pattern and reversal of impaired hepatic mono-oxygenases by phenobarbital in rats with developing and established adjuvant disease.
    Mathur PP, Smyth RD, Witmer CM, Carr GS, Reavey-Cantwell NH.
    J Pharmacol Exp Ther; 1977 Oct; 203(1):169-83. PubMed ID: 909051
    [No Abstract] [Full Text] [Related]

  • 30. Sex-dependent effects of cyclic AMP on the hepatic mixed function oxidase system.
    Ross WE, Simrell C, Oppelt WW.
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):319-32. PubMed ID: 4349298
    [No Abstract] [Full Text] [Related]

  • 31. Polychlorinated biphenyls: comparative effects of high and low chlorine containing Aroclors on hepatic mixed function oxidase.
    Bickers DR, Harber LC, Kappas A, Alvares AP.
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):505-12. PubMed ID: 4624582
    [No Abstract] [Full Text] [Related]

  • 32. KINETICS OF DRUG METABOLISM BY HEPATIC MICROSOMES.
    RUBIN A, TEPHLY TR, MANNERING GJ.
    Biochem Pharmacol; 1964 Jul; 13():1007-16. PubMed ID: 14201123
    [No Abstract] [Full Text] [Related]

  • 33. Inhibitors of hepatic mixed function oxidases--II. Some benzimidazole, benzoxazole and benzothiazole derivatives.
    Holder GM, Little PJ, Ryan AJ, Watson TR.
    Biochem Pharmacol; 1976 Dec 15; 25(24):2747-50. PubMed ID: 1008898
    [No Abstract] [Full Text] [Related]

  • 34. Inhibitors of hepatic mixed function oxidases--V. Inhibition of aminopyrine N-demethylation and enhancement of aniline hydroxylation by benzoxazole derivatives.
    Little PJ, Ryan AJ.
    Biochem Pharmacol; 1982 May 01; 31(9):1795-8. PubMed ID: 7104044
    [No Abstract] [Full Text] [Related]

  • 35. A survey of the response of different strains of mice to substances metabolised by microsomal oxidation; hexobarbitone, zoxazolamine and warfarin.
    Lush IE.
    Chem Biol Interact; 1976 Mar 01; 12(3-4):363-73. PubMed ID: 1253337
    [Abstract] [Full Text] [Related]

  • 36. 1,1-Dichloroethylene inhibition of liver endoplasmic reticulum calcium pump function.
    Moore L.
    Biochem Pharmacol; 1982 Apr 01; 31(7):1463-5. PubMed ID: 7092937
    [Abstract] [Full Text] [Related]

  • 37. Cytogenetic studies on 1,1-dichloroethylene and its two isomers in mammalian cells in vitro and in vivo.
    Sawada M, Sofuni T, Ishidate M.
    Mutat Res; 1987 Mar 01; 187(3):157-63. PubMed ID: 3821769
    [Abstract] [Full Text] [Related]

  • 38. Decrease in the activity of the drug-metabolizing enzymes of rat liver following the administration of tilorone hydrochloride.
    Leeson GA, Biedenbach SA, Chan KY, Gibson JP, Wright GJ.
    Drug Metab Dispos; 1976 Mar 01; 4(3):232-8. PubMed ID: 6227
    [Abstract] [Full Text] [Related]

  • 39. 1, 1-Dichloroethylene inhibition of liver microsomal calcium pump in vitro.
    Ray P, Moore L.
    Arch Biochem Biophys; 1982 Oct 01; 218(1):26-30. PubMed ID: 7149735
    [No Abstract] [Full Text] [Related]

  • 40. Effect of cimetidine or ranitidine pretreatment on hepatic mixed function oxidase activity in the rat.
    Yee NS, Shargel L.
    Drug Metab Dispos; 1986 Oct 01; 14(5):580-4. PubMed ID: 2876865
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.